首页> 外国专利> NANOCRYSTALLINE FORMULATION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) PROTEASE INHIBITOR USING CELLULOSIC SURFACE STABILIZER, AND METHOD FOR PRODUCING THE FORMULATION

NANOCRYSTALLINE FORMULATION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) PROTEASE INHIBITOR USING CELLULOSIC SURFACE STABILIZER, AND METHOD FOR PRODUCING THE FORMULATION

机译:使用纤维素表面稳定剂的人类免疫缺陷病毒(HIV)蛋白酶抑制剂的纳米晶配方及其制备方法

摘要

PPROBLEM TO BE SOLVED: To provide a stable nanoparticle-containing composition including a slightly soluble crystalline HIV protease inhibitor having a water solubility of less than 10 mg/ml, wherein nanoparticles do not flocculate or agglomerate due to interparticle attractive force. PSOLUTION: The composition includes the slightly soluble crystalline HIV protease inhibitor having the water solubility of less than 10 mg/ml and adsorbing, on its surface, a cellulosic surface stabilizer in an amount sufficient to maintain an effective average particle size of less than 1,000 nm. The surface stabilizer is preferably selected from the group consisting of hydroxypropyl cellulose (HPC), hydroxypropyl methyl cellulose (HPMC), HPC super low viscosity (HPC-SL), and HPC-low viscosity (HPC-L). The HIV protease inhibitor is particularly VX478. PCOPYRIGHT: (C)2010,JPO&INPIT
机译:解决的问题:提供一种稳定的含纳米颗粒的组合物,该组合物包含水溶性小于10 mg / ml的微溶性结晶HIV蛋白酶抑制剂,其中纳米颗粒不会由于颗粒间的吸引力而絮凝或结块。

溶液:该组合物包含水溶性稍低于10 mg / ml的微溶性结晶HIV蛋白酶抑制剂,并且其表面吸附的纤维素表面稳定剂的量足以保持小于或等于10的有效平均粒径。超过1000海里表面稳定剂优选选自羟丙基纤维素(HPC),羟丙基甲基纤维素(HPMC),HPC超低粘度(HPC-SL)和HPC-低粘度(HPC-L)。 HIV蛋白酶抑制剂特别是VX478。

版权:(C)2010,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号